Literature DB >> 6849750

Protein binding of non-steroidal anti-inflammatory drugs in plasma and synovial fluid of arthritic patients.

S Wanwimolruk, P M Brooks, D J Birkett.   

Abstract

1 The protein binding of seven non-steroidal anti-inflammatory drugs (indomethacin, tolmetin, salicylic acid, ibuprofen, flurbiprofen, naproxen and GP53,633) and warfarin was investigated by equilibrium dialysis in simultaneous samples of synovial fluid and plasma from 12 arthritic patients. 2 The protein binding of all drugs studied except warfarin and flurbiprofen was significantly lower in synovial fluid than in plasma. 3 The decreased protein binding of these drugs is likely to explain the lower total drug concentrations found in synovial fluid in comparison to plasma. 4 The lower albumin concentration plays an important role in determination of reduced drug binding in synovial fluid compared to plasma and the fatty acid concentration in synovial fluid may also influence the protein binding of some of these drugs.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6849750      PMCID: PMC1427843          DOI: 10.1111/j.1365-2125.1983.tb01469.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  23 in total

1.  Simultaneous pharmacokinetics of benorylate in plasma and synovial fluid of patients with rheumatoid arthritis.

Authors:  M Aylward; J Maddock; P Rees; G M Thomas; R Wheeldon; F Holly
Journal:  Scand J Rheumatol Suppl       Date:  1975

2.  THE COLORIMETRIC MICRO-DETERMINATION OF NON-ESTERIFIED FATTY ACIDS IN PLASMA.

Authors:  W G DUNCOMBE
Journal:  Clin Chim Acta       Date:  1964-02       Impact factor: 3.786

3.  Simultaneous pharmacokinetics of alclofenace in plasma and synovial fluid in patients with rheumatoid arthritis.

Authors:  G M Thomas; P Rees; J E Dippy; J Maddock
Journal:  Curr Med Res Opin       Date:  1975       Impact factor: 2.580

4.  Plasma and synovial fluid concentrations of acetylsalicylic acid in patients with rheumatoid arthritis.

Authors:  S D Sholkoff; E J Eyring; M Rowland; S Riegelman
Journal:  Arthritis Rheum       Date:  1967-08

5.  Sulfhydryl deficiency in connective tissue disorders: correlation with disease activity and protein alterations.

Authors:  A Lorber; R A Bovy; C C Chang
Journal:  Metabolism       Date:  1971-05       Impact factor: 8.694

6.  Simultaneous pharmacokinetics of indomethacin in serum and synovial fluid.

Authors:  H W Emori; G D Champion; R Bluestone; H E Paulus
Journal:  Ann Rheum Dis       Date:  1973-09       Impact factor: 19.103

7.  Effect of protein binding on levels of ampicillin and cloxacillin in synovial fluid.

Authors:  A Howell; R Sutherland; G N Rolinson
Journal:  Clin Pharmacol Ther       Date:  1972 Sep-Oct       Impact factor: 6.875

8.  Albumin metabolism in rheumatoid arthritis.

Authors:  F C Ballantyne; A Fleck; W C Dick
Journal:  Ann Rheum Dis       Date:  1971-05       Impact factor: 19.103

9.  Investigation of phenylbutazone in synovial fluid.

Authors:  M Farr; J V Willis
Journal:  J Int Med Res       Date:  1977       Impact factor: 1.671

10.  Naproxen concentrations in serum, synovial fluid, and synovium.

Authors:  S Jalava; H Saarimaa; M Anttila; H Sundquist
Journal:  Scand J Rheumatol       Date:  1977       Impact factor: 3.641

View more
  17 in total

Review 1.  Pharmacokinetics of nonsteroidal anti-inflammatory drugs in synovial fluid.

Authors:  R O Day; A J McLachlan; G G Graham; K M Williams
Journal:  Clin Pharmacokinet       Date:  1999-03       Impact factor: 6.447

Review 2.  Recent findings on the pharmacokinetics of non-steroidal anti-inflammatory drugs in synovial fluid.

Authors:  P Netter; B Bannwarth; M J Royer-Morrot
Journal:  Clin Pharmacokinet       Date:  1989-09       Impact factor: 6.447

Review 3.  A comparison of synovial fluid concentrations of non-steroidal anti-inflammatory drugs with their in vitro activity.

Authors:  E Urquhart
Journal:  Agents Actions       Date:  1991-03

4.  Plasma and synovial fluid meclofenamic acid concentrations in patients with rheumatoid arthritis of the knee.

Authors:  J R Koup; D Thomas; E Tucker; A Black; M Ruderman; J A Dixon; A Kinkel
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

Review 5.  Protein binding and stereoselectivity of nonsteroidal anti-inflammatory drugs.

Authors:  F Lapicque; N Muller; E Payan; N Dubois; P Netter
Journal:  Clin Pharmacokinet       Date:  1993-08       Impact factor: 6.447

Review 6.  Articular pharmacokinetics of protein-bound antirheumatic agents.

Authors:  P A Simkin; M P Wu; D M Foster
Journal:  Clin Pharmacokinet       Date:  1993-10       Impact factor: 6.447

7.  Protein binding of non-steroidal anti-inflammatory drugs in rheumatoid arthritis.

Authors:  M L Selley
Journal:  Br J Clin Pharmacol       Date:  1984-03       Impact factor: 4.335

8.  Modeling Sex Differences in Pharmacokinetics, Pharmacodynamics, and Disease Progression Effects of Naproxen in Rats with Collagen-Induced Arthritis.

Authors:  Xiaonan Li; Debra C DuBois; Richard R Almon; William J Jusko
Journal:  Drug Metab Dispos       Date:  2017-02-28       Impact factor: 3.922

Review 9.  Ibuprofen: pharmacology, efficacy and safety.

Authors:  K D Rainsford
Journal:  Inflammopharmacology       Date:  2009-11-21       Impact factor: 4.473

10.  Binding of piroxicam to synovial fluid and plasma proteins in patients with rheumatoid arthritis.

Authors:  Z Trnavská; K Trnavský; D Zlnay
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.